Dimethylmethoxy Chromanyl Palmitate For Skin

2024-05-12 15:35:17

This brightening ingredient dimethylmethoxy chromanyl palmitate for skin blocks tyrosinase which is the main conversion element in melanin production. This inhibits melanin production at both an enzymatic and environmental level in order to protect skin against UV damage.

Brightening the skin as a whole can make the skin look natural, healthy, pure, and radiant.This demand is not even affected by the season. Many women who use whitening products regard whitening as part of their daily life.Therefore, there is an increasing demand for new whitening agents with higher efficiency and safety in the market.


The new whitening and freckle removing agent should have the following characteristics:

★Capable of inhibiting mammalian tyrosinase;

★No toxic or mutagenic;

★It has clinical efficacy;

★Good stability in formulation;

★Novel and protective for formulation stability.

DCP 99% whitening agent is a new unique molecule specially designed for skin whitening, and it has all the characteristics of the above-mentioned new whitening and freckle-removing products.

Use DCP to make emulsion, and put this emulsion at 40°C and room temperature, and measured by HPLC after 0, 1, 2, 3, 4 and 6 months.

Stability studies showed that the concentration of DCP powder whitening agent did not change significantly, while it was still stable after 6 months in oil-in-water emulsion. It is stable in emulsions with different pH values.

Efficacy studies against melasma and freckles:

20 Asian female volunteers, aged 18 to 46. Apply once daily to one side of the face containing 0.1% dimethylmethoxy chromanyl palmitate for skin cream was used on the other side and the other placebo cream was used for 60 days.

Measured before use, 30 and 60 days after treatment, L* (lightness):Blue: placebo cream

Green: dimethylmethoxy chromanyl palmitate

The face cream containing 0.1% DCP whitening agent has a significant whitening effect after 30 days and 60 days of use.

Ten volunteers aged 18 to 70 with melasma or actinic freckles applied a cream containing 0.5% dimethylmethoxy chromanyl palmitate whitening agent to their faces or hands twice a day for 60 days.

Clinical photographic comparisons were made at the beginning of the study and 30 and 60 days after administration.

87% of people with melasma and 77.8% of people with freckles improved significantly after 60 days of use.

Pyran whitening agent market case

Where to Buy dimethylmethoxy chromanyl palmitate for Skin Use?

Please send inquiry to Email: admin@chenlangbio.com